Pilot Study to Validate ex Vivo Expression of Specific Biomarkers of Human Resolutive Macrophages
NCT ID: NCT05106075
Last Updated: 2021-11-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2021-07-07
2024-01-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
biologic sample collection
Blood samples or gingival exsudat collection
blood sample or joint fluid or gingival exudate
blood sample collected by peripheral blood mobilization joint fluid collected by punction gingival exudate collected with paper strips
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
blood sample or joint fluid or gingival exudate
blood sample collected by peripheral blood mobilization joint fluid collected by punction gingival exudate collected with paper strips
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Information and non-opposition for participating in the study
* Patients suffering from periodontitis grade III ou IV
* Patients suffering from microcristalline arthritis
* patient with health insurance
Exclusion Criteria
* pregnancy
* non-compliant patient
* patient with no health insurance
* patient in exclusion period from an other study
* legal incapacity
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Besancon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU Besançon
Besançon, , France
Dentist'S Office
Montbéliard, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Daniel Wendling
Role: primary
Laure Tisserand
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020/562
Identifier Type: -
Identifier Source: org_study_id